Mehrdad Nikfarjam
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research 68
- Cancer-related Molecular Pathways 10
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 16
- Surgery top 2%
- Pancreatitis Pathology and Treatment 22
-
- Gallbladder and Bile Duct Disorders 20
- Gastric Cancer Management and Outcomes 10
- Gastroenterology top 5%
-
- Neuroendocrine Tumor Research Advances 14
-
- Cancer Genomics and Diagnostics 13
- Co-authors
- Christopher ChristophiVijayaragavan MuralidharanHong HeLaurence WeinbergCaterina Malcontenti‐WilsonGraham S. BaldwinKevin F. Staveley-O’CarrollEric T. Kimchi
- Cited by
- OncologyHepatologySurgery
- Journals
- Journal of Clinical Oncology (6 papers)SHILAP Revista de lepidopterología (3 papers)Gastroenterology (1 paper)
- Partner nations
- AustraliaUnited StatesNew Zealand
In The Last Decade
Mehrdad Nikfarjam
166 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 134
- Oncology 1.5k
- Hepatology 423
- Surgery 1.4k
- Pulmonary and Respiratory Medicine 852
- Gastroenterology 128
Countries citing papers authored by Mehrdad Nikfarjam
This map shows the geographic impact of Mehrdad Nikfarjam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehrdad Nikfarjam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehrdad Nikfarjam more than expected).
Fields of papers citing papers by Mehrdad Nikfarjam
This network shows the impact of papers produced by Mehrdad Nikfarjam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehrdad Nikfarjam. The network helps show where Mehrdad Nikfarjam may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mehrdad Nikfarjam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 5 | |
| 3 | 2022 | 19 | |
| 4 | 2021 | 5 | |
| 5 | 2021 | 13 | |
| 6 | 2021 | 5 | |
| 7 | 2019 | 37 | |
| 8 | 2019 | 18 | |
| 9 | 2019 | 16 | |
| 10 | 2019 | 36 | |
| 11 | 2017 | 20 | |
| 12 | 2017 | 21 | |
| 13 | Pancreatic cancer: Is the surgeon still relevant? | 2016 | 0 |
| 14 | 2015 | 54 | |
| 15 | 2015 | 2 | |
| 16 | Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor | 2013 | 1 |
| 17 | 2008 | 63 | |
| 18 | 2005 | 9 | |
| 19 | 2005 | 40 | |
| 20 | 2002 | 5 |
About Mehrdad Nikfarjam
Mehrdad Nikfarjam is a scholar working on Oncology, Hepatology and Surgery, having authored 170 papers that have together received 3.3k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (68 papers), Pancreatitis Pathology and Treatment (22 papers), Gallbladder and Bile Duct Disorders (20 papers), Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Neuroendocrine Tumor Research Advances (14 papers), Cancer Genomics and Diagnostics (13 papers), Cancer-related Molecular Pathways (10 papers) and Gastric Cancer Management and Outcomes (10 papers). The work is most often cited by research in Oncology (1.5k citations), Hepatology (423 citations) and Surgery (1.4k citations). Mehrdad Nikfarjam has collaborated with scholars based in Australia, United States and New Zealand. Frequent co-authors include Christopher Christophi, Vijayaragavan Muralidharan, Hong He, Laurence Weinberg, Caterina Malcontenti‐Wilson, Graham S. Baldwin, Kevin F. Staveley-O’Carroll, Eric T. Kimchi, Niraj J. Gusani and Dannel Yeo. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.